TGFα Activators
TGFα activators constitute a diverse class of compounds with a distinct impact on the activation of transforming growth factor alpha (TGFα). Among these, Erlotinib emerges as a prominent member. It operates by inhibiting the tyrosine kinase activity of the epidermal growth factor receptor (EGFR), thereby enhancing the release of TGFα. This small molecule disrupts the autophosphorylation process of EGFR, a pivotal step in TGFα activation. The Erlotinib-TGFα axis plays a crucial role in cellular proliferation and differentiation, particularly in epithelial tissues. By modulating this pathway, Erlotinib effectively upregulates TGFα activity, influencing cellular responses and molecular cascades related to growth and differentiation. Another key compound within the TGFα activator category is Gefitinib. Like Erlotinib, Gefitinib belongs to the family of tyrosine kinase inhibitors targeting EGFR. Its mechanism of action involves the blockade of ATP-binding sites on the receptor, hindering phosphorylation and consequently promoting TGFα release. Gefitinib's impact on TGFα activation is pivotal in regulating cell proliferation, migration, and survival, with implications for tissue homeostasis. Understanding the intricate molecular interactions facilitated by Gefitinib elucidates its role as a potent TGFα activator, contributing to the modulation of cellular processes pivotal in maintaining tissue integrity.
Sorafenib is another noteworthy member of the TGFα activator class. This multitargeted kinase inhibitor disrupts the RAF/MEK/ERK signaling cascade, affecting various cellular processes, including the release of TGFα. Sorafenib's interference with these signaling pathways results in the activation of TGFα, thereby influencing downstream molecular events associated with cell growth and differentiation. The intricate interplay between Sorafenib and TGFα sheds light on the regulatory mechanisms governing cellular responses in various tissues. This compound, within the broader spectrum of TGFα activators, showcases the intricate relationships between small molecules and the modulation of specific growth factors.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA, a diester of phorbol, acts as an indirect activator of TGFα by influencing the PKC signaling pathway. PMA activates PKC, which in turn phosphorylates and activates transcription factors involved in TGFα gene expression. The resulting increase in TGFα levels promotes its binding to EGFR, initiating downstream signaling cascades. PMA's indirect activation of TGFα through the PKC pathway establishes it as a chemical inducer of TGFα-mediated cellular processes. | ||||||
Ionomycin, free acid | 56092-81-0 | sc-263405 sc-263405A | 1 mg 5 mg | $96.00 $264.00 | 2 | |
Ionomycin, a calcium ionophore, serves as an indirect activator of TGFα by modulating intracellular calcium levels. Ionomycin induces calcium influx, leading to the activation of PKC and subsequent phosphorylation of transcription factors involved in TGFα gene expression. Elevated TGFα levels result in enhanced EGFR activation and downstream signaling. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin, an adenylate cyclase activator, acts as an indirect activator of TGFα by influencing the cAMP/PKA signaling pathway. Forskolin elevates intracellular cAMP levels, activating PKA. Activated PKA phosphorylates transcription factors involved in TGFα gene expression, leading to increased TGFα levels. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Retinoic acid, a derivative of vitamin A, serves as an indirect activator of TGFα by influencing retinoic acid receptor (RAR) signaling. Upon binding to RAR, retinoic acid induces conformational changes that enhance TGFα gene expression. Increased TGFα levels then activate EGFR, initiating downstream signaling cascades. Retinoic acid's indirect activation of TGFα through RAR signaling establishes it as a potential chemical inducer of TGFα-mediated cellular processes. | ||||||
Butyric acid | 107-92-6 | sc-214640 sc-214640A | 1 kg 10 kg | $64.00 $177.00 | ||
Butyric acid, a short-chain fatty acid, acts as an indirect activator of TGFα by influencing histone acetylation. By inhibiting histone deacetylases (HDACs), butyric acid enhances histone acetylation at the TGFα gene promoter, promoting its expression. Increased TGFα levels activate EGFR, initiating downstream signaling cascades. Butyric acid's indirect activation of TGFα through epigenetic regulation establishes it as a potential chemical inducer of TGFα-mediated cellular processes. | ||||||
Sodium Butyrate | 156-54-7 | sc-202341 sc-202341B sc-202341A sc-202341C | 250 mg 5 g 25 g 500 g | $31.00 $47.00 $84.00 $222.00 | 19 | |
Sodium butyrate, a histone deacetylase (HDAC) inhibitor, serves as an indirect activator of TGFα by modulating histone acetylation. By inhibiting HDACs, sodium butyrate enhances histone acetylation at the TGFα gene promoter, promoting its expression. Increased TGFα levels activate EGFR, initiating downstream signaling cascades. Sodium butyrate's indirect activation of TGFα through epigenetic regulation establishes it as a potential chemical inducer of TGFα-mediated cellular processes. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $55.00 $131.00 $203.00 $317.00 | 23 | |
A23187, a calcium ionophore, acts as a direct activator of TGFα by modulating calcium signaling. A23187 induces an influx of calcium ions, activating PKC and leading to the phosphorylation of transcription factors involved in TGFα gene expression. Increased TGFα levels activate EGFR, initiating downstream signaling cascades. A23187's direct activation of TGFα | ||||||